Mark S. Eberhardt

15.0k total citations · 6 hit papers
69 papers, 11.0k citations indexed

About

Mark S. Eberhardt is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Mark S. Eberhardt has authored 69 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Genetics and 11 papers in Surgery. Recurrent topics in Mark S. Eberhardt's work include Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers), Diabetes Management and Research (13 papers) and Diabetes and associated disorders (13 papers). Mark S. Eberhardt is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers), Diabetes Management and Research (13 papers) and Diabetes and associated disorders (13 papers). Mark S. Eberhardt collaborates with scholars based in United States, Thailand and Japan. Mark S. Eberhardt's co-authors include Catherine C. Cowie, Katherine M. Flegal, Danita D. Byrd-Holt, Maureen I Harris, Sharon Saydah, Randie R. Little, Hsiao-Mei Wiedmeyer, David E. Goldstein, Elsie R. Pamuk and Linda S. Geiss and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Neurology.

In The Last Decade

Mark S. Eberhardt

68 papers receiving 10.4k citations

Hit Papers

Prevalence of Diabetes, I... 1998 2026 2007 2016 1998 2006 2008 2013 1999 500 1000 1.5k 2.0k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark S. Eberhardt 5.0k 2.2k 1.5k 1.4k 1.4k 69 11.0k
Desmond E. Williams 4.8k 1.0× 1.4k 0.6× 1.8k 1.2× 1.5k 1.1× 1.4k 1.0× 99 9.9k
Maureen I Harris 7.6k 1.5× 2.3k 1.1× 1.3k 0.9× 1.6k 1.1× 1.4k 1.0× 84 12.6k
Nikhil Tandon 3.8k 0.8× 1.6k 0.7× 1.8k 1.2× 1.2k 0.9× 1.4k 1.0× 513 11.7k
Timothy A. Welborn 3.7k 0.7× 1.2k 0.6× 2.0k 1.4× 1.9k 1.4× 991 0.7× 108 8.9k
Peter T. Donnan 2.5k 0.5× 1.6k 0.7× 1.3k 0.8× 1.4k 1.0× 2.5k 1.8× 260 13.1k
Helen P. Hazuda 3.6k 0.7× 1.4k 0.6× 2.2k 1.4× 1.9k 1.4× 1.2k 0.9× 156 10.0k
Knut Borch‐Johnsen 4.6k 0.9× 1.7k 0.8× 1.6k 1.1× 2.1k 1.5× 1.6k 1.2× 206 12.3k
Joseph V. Selby 3.2k 0.6× 1.8k 0.8× 1.3k 0.9× 955 0.7× 1.4k 1.0× 110 10.5k
Catherine C. Cowie 9.1k 1.8× 2.7k 1.3× 2.1k 1.4× 2.1k 1.5× 2.1k 1.5× 113 16.0k
Angela Döring 2.2k 0.4× 2.7k 1.2× 1.4k 1.0× 1.9k 1.3× 1.3k 0.9× 181 11.2k

Countries citing papers authored by Mark S. Eberhardt

Since Specialization
Citations

This map shows the geographic impact of Mark S. Eberhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Eberhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Eberhardt more than expected).

Fields of papers citing papers by Mark S. Eberhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Eberhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Eberhardt. The network helps show where Mark S. Eberhardt may publish in the future.

Co-authorship network of co-authors of Mark S. Eberhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Eberhardt. A scholar is included among the top collaborators of Mark S. Eberhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Eberhardt. Mark S. Eberhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Albertorio‐Diaz, Juan Rafael, Mark S. Eberhardt, María A. Oquendo, et al.. (2017). Depressive states among adults with diabetes: Findings from the National Health and Nutrition Examination Survey, 2007–2012. Diabetes Research and Clinical Practice. 127. 80–88. 21 indexed citations
2.
Murphy, Daniel P., Charles E. McCulloch, Feng Lin, et al.. (2016). Trends in Prevalence of Chronic Kidney Disease in the United States. Annals of Internal Medicine. 165(7). 473–481. 428 indexed citations breakdown →
3.
Lazo, Mariana, Rubén Hernáez, Mark S. Eberhardt, et al.. (2013). Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994. American Journal of Epidemiology. 178(1). 38–45. 639 indexed citations breakdown →
4.
Plantinga, Laura, Vanessa Grubbs, Urmimala Sarkar, et al.. (2011). Nonsteroidal Anti-Inflammatory Drug Use Among Persons With Chronic Kidney Disease in the United States. The Annals of Family Medicine. 9(5). 423–430. 92 indexed citations
5.
Plantinga, Laura, Deidra C. Crews, Josef Coresh, et al.. (2010). Prevalence of Chronic Kidney Disease in US Adults with Undiagnosed Diabetes or Prediabetes. Clinical Journal of the American Society of Nephrology. 5(4). 673–682. 290 indexed citations
6.
Dorsey, Rashida, Mark S. Eberhardt, Edward W. Gregg, & Linda S. Geiss. (2009). Control of risk factors among people with diagnosed diabetes, by lower extremity disease status.. PubMed Central. 9 indexed citations
7.
Dorsey, Rashida, Mark S. Eberhardt, & Cynthia L. Ogden. (2009). Racial/Ethnic Differences in Weight Perception. Obesity. 17(4). 790–795. 173 indexed citations
8.
Saydah, Sharon & Mark S. Eberhardt. (2006). Use of Complementary and Alternative Medicine Among Adults with Chronic Diseases: United States 2002. The Journal of Alternative and Complementary Medicine. 12(8). 805–812. 204 indexed citations
9.
Barofsky, Ivan, P.S. Erickson, & Mark S. Eberhardt. (2004). Comparison of a single global item and an index of a multi-item health status measure among persons with and without diabetes in the US. Quality of Life Research. 13(10). 1671–1681. 15 indexed citations
10.
Erlinger, Thomas P., Michelle Tarver-Carr, Neil R. Powe, et al.. (2003). Leukocytosis, hypoalbuminemia, and the risk for chronic kidney disease in US adults. American Journal of Kidney Diseases. 42(2). 256–263. 63 indexed citations
11.
Powe, Neil R., Michelle Tarver-Carr, Mark S. Eberhardt, & Frederick L. Brancati. (2003). Receipt of renal replacement therapy in the United States: a population-based study of sociodemographic disparities from the second national health and nutrition examination survey (NHANES II). American Journal of Kidney Diseases. 42(2). 249–255. 27 indexed citations
12.
Jones, Camille A., Mildred E. Francis, Mark S. Eberhardt, et al.. (2002). Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey. American Journal of Kidney Diseases. 39(3). 445–459. 328 indexed citations
13.
Tarver-Carr, Michelle, Neil R. Powe, Mark S. Eberhardt, et al.. (2002). Excess Risk of Chronic Kidney Disease among African-American versus White Subjects in the United States. Journal of the American Society of Nephrology. 13(9). 2363–2370. 229 indexed citations
14.
Harris, Maureen I, Catherine C. Cowie, Ken Gu, et al.. (2002). Higher fasting insulin but lower fasting C‐peptide levels in African Americans in the US population. Diabetes/Metabolism Research and Reviews. 18(2). 149–155. 43 indexed citations
15.
Earnest, Michael P., Jill M. Norris, Mark S. Eberhardt, & George H. Sands. (1996). Report of the AAN Task Force on access to health care. Neurology. 46(5). 1471–1471. 13 indexed citations
16.
Madans, Jennifer H., et al.. (1995). Differences in morbidity measures and risk factor identification using multiple data sources: The case of coronary heart disease. Statistics in Medicine. 14(5-7). 643–653. 23 indexed citations
17.
Eberhardt, Mark S., et al.. (1994). Is race related to glycemic control? An assessment of glycosylated hemoglobin in two South Carolina communities. Journal of Clinical Epidemiology. 47(10). 1181–1189. 46 indexed citations
18.
Geiss, Linda S., William H. Herman, Merilyn G. Goldschmid, et al.. (1993). Surveillance for diabetes mellitus--United States, 1980-1989.. PubMed. 42(2). 1–20. 56 indexed citations
19.
O’Leary, Leslie A., Janice S. Dorman, Ronald E. LaPorte, et al.. (1991). Familial and sporadic insulin-dependent diabetes: evidence for heterogeneous etiologies?. Diabetes Research and Clinical Practice. 14(3). 183–190. 35 indexed citations
20.
Kuller, Lewis H., Dorothy Becker, Karen J. Cruickshanks, et al.. (1990). Evolution of the Pittsburgh studies of the epidemiology of insulin‐dependent diabetes mellitus. Genetic Epidemiology. 7(2). 105–119. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026